World’s First Lung Cancer Vaccine Trials Are Now Running in Seven Countries
Lung cancer is the most common cancer worldwide, taking 1.8 million lives annually. Traditionally combated using surgery, radiation, and chemotherapy, survival rates have improved. But now, a new vaccine is looking to stop the cancer by harnessing the body's immune system. Trials for the world's first lung cancer vaccine have started in 34 research centers across seven countries.